Yoko Koh

854 total citations
25 papers, 228 citations indexed

About

Yoko Koh is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Surgery. According to data from OpenAlex, Yoko Koh has authored 25 papers receiving a total of 228 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 10 papers in Cancer Research and 9 papers in Surgery. Recurrent topics in Yoko Koh's work include Bladder and Urothelial Cancer Treatments (7 papers), Renal cell carcinoma treatment (5 papers) and Cancer Genomics and Diagnostics (5 papers). Yoko Koh is often cited by papers focused on Bladder and Urothelial Cancer Treatments (7 papers), Renal cell carcinoma treatment (5 papers) and Cancer Genomics and Diagnostics (5 papers). Yoko Koh collaborates with scholars based in Japan, United States and Malaysia. Yoko Koh's co-authors include Motohide Uemura, Taigo Kato, Koji Hatano, Takeshi Ujike, Atsunari Kawashima, Norio Nonomura, Eisuke Tomiyama, Makoto Matsushita, Yujiro Hayashi and Yu Ishizuya and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Diabetes.

In The Last Decade

Yoko Koh

23 papers receiving 224 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yoko Koh Japan	10	102	85	77	70	70	25	228
Masataka Shimonosono Japan	10	124 1.2×	77 0.9×	104 1.4×	67 1.0×	114 1.6×	29	286
Juliane Perner United Kingdom	9	142 1.4×	84 1.0×	73 0.9×	91 1.3×	72 1.0×	12	282
Yunping Zhao China	11	184 1.8×	68 0.8×	94 1.2×	43 0.6×	50 0.7×	27	297
Jimin Min United States	9	97 1.0×	52 0.6×	51 0.7×	84 1.2×	74 1.1×	15	228
Brian D. Robinson United States	7	120 1.2×	81 1.0×	46 0.6×	108 1.5×	53 0.8×	9	262
Yelong Chen China	9	168 1.6×	44 0.5×	87 1.1×	28 0.4×	79 1.1×	11	274
Ian Y. Luk Australia	9	134 1.3×	29 0.3×	48 0.6×	35 0.5×	61 0.9×	11	214
Shi‐Xun Lu China	12	109 1.1×	96 1.1×	64 0.8×	53 0.8×	120 1.7×	21	277
Maria Lucia Iacovino Italy	6	56 0.5×	72 0.8×	35 0.5×	56 0.8×	134 1.9×	13	232
Masafumi Sada Japan	7	64 0.6×	23 0.3×	71 0.9×	51 0.7×	136 1.9×	15	221

Countries citing papers authored by Yoko Koh

Since Specialization

Citations

This map shows the geographic impact of Yoko Koh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoko Koh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoko Koh more than expected).

Fields of papers citing papers by Yoko Koh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoko Koh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoko Koh. The network helps show where Yoko Koh may publish in the future.

Co-authorship network of co-authors of Yoko Koh

This figure shows the co-authorship network connecting the top 25 collaborators of Yoko Koh. A scholar is included among the top collaborators of Yoko Koh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoko Koh. Yoko Koh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Koh, Yoko, Woon Chan Chong, Kok Chung Chong, & Yean Ling Pang. (2025). Water responsive chitosan/polyacrylamide self-healable coating for polyethersulfone membrane. Pure and Applied Chemistry. 97(8). 929–943. 1 indexed citations

Chong, Kok Chung, et al.. (2025). Development and Performance Evaluation of Self-Healing PVA-PAA-Coated PES Membrane for Water Pollution Mitigation. SHILAP Revista de lepidopterología. 23–23.

Yamamichi, Gaku, Taigo Kato, Noriaki Arakawa, et al.. (2024). GDF15 propeptide promotes bone metastasis of castration-resistant prostate cancer by augmenting the bone microenvironment. Biomarker Research. 12(1). 147–147. 3 indexed citations

Kawata, Satoshi, Junji Kozawa, S. Yoneda, et al.. (2023). Inflammatory Cell Infiltration Into Islets Without PD-L1 Expression Is Associated With the Development of Immune Checkpoint Inhibitor–Related Type 1 Diabetes in Genetically Susceptible Patients. Diabetes. 72(4). 511–519. 12 indexed citations

Jingushi, Kentaro, Atsunari Kawashima, Takuro Saito, et al.. (2022). Circulating extracellular vesicles carrying Firmicutes reflective of the local immune status may predict clinical response to pembrolizumab in urothelial carcinoma patients. Cancer Immunology Immunotherapy. 71(12). 2999–3011. 10 indexed citations

Yamamoto, Akinaru, Atsunari Kawashima, Toshihiro Uemura, et al.. (2022). Biological distinction between grades 2 and 3 with respect to intravesical recurrence in T1 high-grade bladder tumors: a retrospective study. BMC Urology. 22(1). 59–59. 1 indexed citations

Koh, Yoko, Kosuke Nakano, Kotoe Katayama, et al.. (2022). Early dynamics of circulating tumor DNA predict clinical response to immune checkpoint inhibitors in metastatic renal cell carcinoma. International Journal of Urology. 29(5). 462–469. 9 indexed citations

Yamamichi, Gaku, Taigo Kato, Eisuke Tomiyama, et al.. (2022). Diagnostic and prognostic significance of tartrate‐resistant acid phosphatase type 5b in newly diagnosed prostate cancer with bone metastasis: A real‐world multi‐institutional study. International Journal of Urology. 30(1). 70–76. 8 indexed citations

Kato, Taigo, Kazuma Kiyotani, Eisuke Tomiyama, et al.. (2021). Peripheral T cell receptor repertoire features predict durable responses to anti-PD-1 inhibitor monotherapy in advanced renal cell carcinoma. OncoImmunology. 10(1). 1862948–1862948. 29 indexed citations

10.

Hayashi, Yujiro, Kazutoshi Fujita, Kyosuke Matsuzaki, et al.. (2020). Clinical Significance of Hotspot Mutation Analysis of Urinary Cell-Free DNA in Urothelial Bladder Cancer. Frontiers in Oncology. 10. 755–755. 32 indexed citations

11.

Kato, Taigo, Eisuke Tomiyama, Yoko Koh, et al.. (2020). A Potential Mechanism of Anticancer Immune Response Coincident With Immune-related Adverse Events in Patients With Renal Cell Carcinoma. Anticancer Research. 40(9). 4875–4883. 9 indexed citations

12.

Hayashi, Yujiro, Kazutoshi Fujita, Satoshi Nojima, et al.. (2020). TERT C228T mutation in non‐malignant bladder urothelium is associated with intravesical recurrence for patients with non‐muscle invasive bladder cancer. Molecular Oncology. 14(10). 2375–2383. 24 indexed citations

13.

Koh, Yoko, Atsunari Kawashima, Takeshi Ujike, et al.. (2020). Failure to achieve castrate level of serum testosterone during luteinizing hormone-releasing hormone agonist therapy in a patient with prostate cancer. Anti-Cancer Drugs. 31(10). 1099–1102. 1 indexed citations

14.

Ishizuya, Yu, Motohide Uemura, Ryohei Narumi, et al.. (2020). The role of actinin-4 (ACTN4) in exosomes as a potential novel therapeutic target in castration-resistant prostate cancer. Biochemical and Biophysical Research Communications. 523(3). 588–594. 34 indexed citations

15.

Wang, Cong, Motohide Uemura, Eisuke Tomiyama, et al.. (2020). MicroRNA‐92b‐3p is a prognostic oncomiR that targets TSC1 in clear cell renal cell carcinoma. Cancer Science. 111(4). 1146–1155. 22 indexed citations

16.

Kawashima, Atsunari, Takayuki Kanazawa, Tetsuya Yoshida, et al.. (2020). MP18-02 IDENTIFICATION OF CCR8 AS A SPECIFIC MARKER OF TUMOR TISSUE-INFILTRATING REGULATORY T CELLS AND ITS POSSIBILITY AS A THERAPEUTIC TARGET IN RENAL CELL CARCINOMA. The Journal of Urology. 203. e234–e234. 1 indexed citations

17.

Park, Sung Yong, et al.. (2019). Association between 18F-FDG uptake in PET/CT, Nrf2 and NQO1 expression and their prognostic significance in non-small cell lung cancer. Neoplasma. 66(4). 619–626. 8 indexed citations

18.

Koh, Yoko, Takeshi Ujike, Kazutoshi Fujita, et al.. (2019). [A Case of Urethral Carcinoma in Situ Resected by Urethrectomy of Anterior Urethra].. PubMed. 65(8). 337–340. 1 indexed citations

19.

Koh, Yoko, Hirotsugu Kenmotsu, Masakuni Serizawa, et al.. (2013). MC13-0079 Prospective mutational characterization of Japanese patients with non-small cell lung cancer using surgically resected tumor specimens by next-generation sequencing. European Journal of Cancer. 49. S12–S12. 1 indexed citations

20.

Hong, Min, et al.. (2010). Sunitinib for unselected Korean patients with advanced renal cell carcinoma: A comparable efficacy with different toxicity profiles.. Journal of Clinical Oncology. 28(15_suppl). e15107–e15107. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact